Radiodermatitis
Chapter 12:Diseases of the skin and subcutaneous tissue
ICD-10 L58 is a used to indicate a diagnosis of radiodermatitis.
Radiodermatitis, classified under ICD-10 code L58, refers to skin damage resulting from exposure to ionizing radiation. Clinically, it presents as erythema, desquamation, and in severe cases, ulceration of the skin. The anatomy involved primarily includes the epidermis and dermis, where radiation exposure disrupts cellular integrity and leads to inflammatory responses. Disease progression can vary; initial symptoms may appear within days to weeks post-exposure, depending on the dose and duration of radiation. Chronic cases may develop into fibrosis or skin necrosis. Diagnostic considerations include a thorough patient history of radiation exposure, clinical examination of skin lesions, and, if necessary, biopsy to rule out other dermatological conditions. Radiodermatitis is often seen in patients undergoing radiation therapy for cancer treatment, making it crucial for healthcare providers to monitor skin integrity throughout the treatment process.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L58 covers conditions specifically related to skin damage from radiation exposure, including acute radiodermatitis, chronic radiodermatitis, and radiation-induced skin changes. Diagnostic criteria include clinical presentation of skin lesions and history of radiation exposure.
L58 should be used when the skin condition is directly attributable to radiation exposure. It is differentiated from other dermatitis codes by the specific history of radiation treatment or exposure.
Documentation should include a detailed patient history of radiation exposure, clinical notes describing the skin condition, treatment plans, and any imaging or biopsy results that support the diagnosis of radiodermatitis.